PYVSX
Price
$17.46
Change
+$0.01 (+0.06%)
Updated
Oct 6 closing price
Net Assets
1.06B
RMFCX
Price
$62.20
Change
+$0.11 (+0.18%)
Updated
Oct 6 closing price
Net Assets
112.47B
Interact to see
Advertisement

PYVSX vs RMFCX

Header iconPYVSX vs RMFCX Comparison
Open Charts PYVSX vs RMFCXBanner chart's image
Payden Equity Income SI
Price$17.46
Change+$0.01 (+0.06%)
VolumeN/A
Net Assets1.06B
American Funds American Mutual R3
Price$62.20
Change+$0.11 (+0.18%)
VolumeN/A
Net Assets112.47B
PYVSX vs RMFCX Comparison Chart in %
View a ticker or compare two or three
VS
PYVSX vs. RMFCX commentary
Oct 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PYVSX is a Buy and RMFCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 112B vs. PYVSX (1.06B). RMFCX pays higher dividends than PYVSX: RMFCX (1.20) vs PYVSX (1.08). PYVSX was incepted earlier than RMFCX: PYVSX (11 years) vs RMFCX (23 years). RMFCX (0.91) is less costly to investors than PYVSX (0.76). PYVSX is a more actively managed with annual turnover of: 80.00 vs. RMFCX (31.00). RMFCX has a lower initial minimum investment than PYVSX: RMFCX (250) vs PYVSX (10000000). RMFCX annual gain was more profitable for investors over the last year : 7.44 vs. PYVSX (-7.20). RMFCX return over 5 years is better than : 60.80 vs. PYVSX (15.34).
PYVSXRMFCXPYVSX / RMFCX
Total Expense Ratio0.660.9173%
Annual Report Gross Expense Ratio0.760.9184%
Fund Existence11 years23 years-
Gain YTD8.63614.96458%
Front LoadN/AN/A-
Min. Initial Investment100000002504,000,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.06B112B1%
Annual Yield % from dividends1.081.2090%
Returns for 1 year-7.207.44-97%
Returns for 3 years16.8743.8438%
Returns for 5 years15.3460.8025%
Returns for 10 years59.2894.2163%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UFPT201.936.71
+3.44%
UFP Technologies
VMI400.365.74
+1.45%
Valmont Industries
FRMEP25.80N/A
N/A
First Merchants Corp
LXEO6.47-0.15
-2.27%
Lexeo Therapeutics
KPTI6.16-0.22
-3.45%
Karyopharm Therapeutics Inc.